GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Conduit Pharmaceuticals Inc (FRA:ZK70) » Definitions » Common Stock

Conduit Pharmaceuticals (FRA:ZK70) Common Stock : €0.01 Mil (As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Conduit Pharmaceuticals Common Stock?

Conduit Pharmaceuticals's quarterly common stock increased from Jun. 2024 (€0.01 Mil) to Sep. 2024 (€0.01 Mil) and increased from Sep. 2024 (€0.01 Mil) to Dec. 2024 (€0.01 Mil).

Conduit Pharmaceuticals's annual common stock stayed the same from Dec. 2022 (€0.01 Mil) to Dec. 2023 (€0.01 Mil) but then increased from Dec. 2023 (€0.01 Mil) to Dec. 2024 (€0.01 Mil).

Conduit Pharmaceuticals Common Stock Historical Data

The historical data trend for Conduit Pharmaceuticals's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Conduit Pharmaceuticals Common Stock Chart

Conduit Pharmaceuticals Annual Data
Trend Dec21 Dec22 Dec23 Dec24
Common Stock
- 0.01 0.01 0.01

Conduit Pharmaceuticals Quarterly Data
Dec21 Mar22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.01 0.01 0.01 0.01 0.01

Conduit Pharmaceuticals Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Conduit Pharmaceuticals Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Conduit Pharmaceuticals Inc (FRA:ZK70) » Definitions » Common Stock
Comparable Companies
CMND SNGX SILO NLSP CELZ ADTX CPMV PKTX ACUT VRAX VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
CDT:USA
Address
4995 Murphy Canyon Road, Suite 300, San Diego, CA, USA, 92123
Website
https://www.conduitpharma.com
Conduit Pharmaceuticals Inc is a clinical-stage specialty biopharmaceutical company that was formed to facilitate the development and commercialization of clinical assets that have not been or are not being, prioritized by biopharmaceutical companies to develop pharmaceutical products that meet the unmet medical needs of patients. The Company's current development pipeline includes a glucokinase activator, which is Phase II ready for autoimmune diseases including uveitis, Hashimoto's Thyroiditis, preterm labor, and renal transplant rejection. The Company's development pipeline also includes a potent, irreversible inhibitor of human Myeloperoxidase (MPO) that has the potential to treat idiopathic male infertility.

Conduit Pharmaceuticals Headlines

No Headlines